These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10989121)

  • 21. Indices of oxidative stress in Parkinson's disease, Alzheimer's disease and dementia with Lewy bodies.
    Owen AD; Schapira AH; Jenner P; Marsden CD
    J Neural Transm Suppl; 1997; 51():167-73. PubMed ID: 9470137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TorsinA accumulation in Lewy bodies in sporadic Parkinson's disease.
    Shashidharan P; Good PF; Hsu A; Perl DP; Brin MF; Olanow CW
    Brain Res; 2000 Sep; 877(2):379-81. PubMed ID: 10986355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.
    Baba M; Nakajo S; Tu PH; Tomita T; Nakaya K; Lee VM; Trojanowski JQ; Iwatsubo T
    Am J Pathol; 1998 Apr; 152(4):879-84. PubMed ID: 9546347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of oxidative damage in protein aggregation associated with Parkinson's disease and related disorders.
    Norris EH; Giasson BI
    Antioxid Redox Signal; 2005; 7(5-6):672-84. PubMed ID: 15890012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pael-R is accumulated in Lewy bodies of Parkinson's disease.
    Murakami T; Shoji M; Imai Y; Inoue H; Kawarabayashi T; Matsubara E; Harigaya Y; Sasaki A; Takahashi R; Abe K
    Ann Neurol; 2004 Mar; 55(3):439-42. PubMed ID: 14991825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of Lewy bodies and glial cytoplasmic inclusions in the brain of Parkinson's disease.
    Mochizuki A; Komatsuzaki Y; Shoji S
    Acta Neuropathol; 2002 Nov; 104(5):534-7. PubMed ID: 12410401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein aggregation in the pathogenesis of familial and sporadic Parkinson's disease.
    McNaught KS; Olanow CW
    Neurobiol Aging; 2006 Apr; 27(4):530-45. PubMed ID: 16207501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody to an abnormal protein in amyotrophic lateral sclerosis identifies Lewy body-like inclusions in ALS and Lewy bodies in Parkinson's disease.
    Mather K; Watts FZ; Carroll M; Whitehead P; Swash M; Cairn N; Burke J
    Neurosci Lett; 1993 Sep; 160(1):13-6. PubMed ID: 8247323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathological proteins in Parkinson's disease: focus on the proteasome.
    Snyder H; Wolozin B
    J Mol Neurosci; 2004; 24(3):425-42. PubMed ID: 15655264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of ubiquitin linkages on alpha-synuclein induced-toxicity in a Drosophila model of Parkinson's disease.
    Lee FK; Wong AK; Lee YW; Wan OW; Chan HY; Chung KK
    J Neurochem; 2009 Jul; 110(1):208-19. PubMed ID: 19457126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pathogenesis of Parkinson's disease: a common pathway between alpha-synuclein and parkin and the mechanism of Lewy bodies formation].
    Hattori N; Machida Y; Noda K
    Rinsho Shinkeigaku; 2005 Nov; 45(11):905-7. PubMed ID: 16447759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.
    Lo Bianco C; Ridet JL; Schneider BL; Deglon N; Aebischer P
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10813-8. PubMed ID: 12122208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dopaminergic neuronal death in Parkinson's disease: is accumulation of unfolded proteins a cause or effect?].
    Imai Y; Takahashi R
    Tanpakushitsu Kakusan Koso; 2004 May; 49(7 Suppl):1113-7. PubMed ID: 15168542
    [No Abstract]   [Full Text] [Related]  

  • 34. Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for alpha-synuclein.
    Arawaka S; Saito Y; Murayama S; Mori H
    Neurology; 1998 Sep; 51(3):887-9. PubMed ID: 9748051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New aspects of the pathology of neurodegenerative disorders as revealed by ubiquitin antibodies.
    Leigh PN; Probst A; Dale GE; Power DP; Brion JP; Dodson A; Anderton BH
    Acta Neuropathol; 1989; 79(1):61-72. PubMed ID: 2555999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies.
    Spillantini MG; Crowther RA; Jakes R; Cairns NJ; Lantos PL; Goedert M
    Neurosci Lett; 1998 Jul; 251(3):205-8. PubMed ID: 9726379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.
    Ardley HC; Scott GB; Rose SA; Tan NG; Robinson PA
    J Neurochem; 2004 Jul; 90(2):379-91. PubMed ID: 15228595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pro-apoptotic protein glyceraldehyde-3-phosphate dehydrogenase promotes the formation of Lewy body-like inclusions.
    Tsuchiya K; Tajima H; Kuwae T; Takeshima T; Nakano T; Tanaka M; Sunaga K; Fukuhara Y; Nakashima K; Ohama E; Mochizuki H; Mizuno Y; Katsube N; Ishitani R
    Eur J Neurosci; 2005 Jan; 21(2):317-26. PubMed ID: 15673432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
    Olanow CW; Brundin P
    Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Co-association of parkin and alpha-synuclein.
    Choi P; Golts N; Snyder H; Chong M; Petrucelli L; Hardy J; Sparkman D; Cochran E; Lee JM; Wolozin B
    Neuroreport; 2001 Sep; 12(13):2839-43. PubMed ID: 11588587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.